36
Views
42
CrossRef citations to date
0
Altmetric
Original Article

Frequent Occurrence of Non-Specific Gliadin Antibodies in Chronic Liver Disease Endomysial but Not Gliadin Antibodies Predict Coeliac Disease in Patients with Chronic Liver Disease

, &
Pages 1162-1167 | Received 24 Feb 1997, Accepted 16 Jul 1997, Published online: 08 Jul 2009

References

  • Mehal W Z, Gregory W L, Lo Y M, Cross S J, Fleming K A, Bassendine M F, et al. Defining the immunogenetic susceptibility to primary biliary cirrhosis. Hepatology 1994; 20: 1213–9
  • Thorsby E. HLA‐associated disease susceptibility–which genes are primarily involved?. Immunologist 1995; 3/2: 51–8
  • Logan R F A, Ferguson A, Finlayson N D C, Weir D G. Primary biliary cirrhosis and coeliac disease, an association?. Lancet 1978; 1: 230–3
  • Olsson R, Kagevi I, Rydberg L. On the concurrence of primary biliary cirrhosis and intestinal villous atrophy. Scand J Gastroenterol 1982; 17: 625–8
  • Löfgren J, Järnerot G, Danielsson D, Hemdal I. Incidence and prevalence of primary biliary cirrhosis in a defined population in Sweden. Scand J Gastroenterol 1985; 20: 647–50
  • Lindberg J, Åhrén C, Iwarsson S. Intestinal villous atrophy in chronic active hepatitis. Scand J Gastroenterol 1979; 14: 1015–8
  • Hay J E, Wiesner R H, Shorter R G, LaRusso N F, Baldus W P. Primary sclerosing cholangitis and celiac disease. Ann Intern Med 1988; 109: 713–7
  • Lindgren S, SjüBerg K, Eriksson S. Unsuspected coeliac disease in chronic ‘cryptogenic’ liver disease. Scand J Gastroenterol 1994; 29: 661–4
  • Sjöberg K, Aim R, Ivarsson S A, Lindstrom C, Eriksson S. Prevalence and clinical significance of gliadin antibodies in healthy children and adults. Scand J Gastroenterol 1994; 29: 248–54
  • Corrao G, Corazza G R, Andreani M L, Torchio P, Valentini R A, Galatola G, et al. Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. Gut 1994; 35: 771–5
  • Grodzinsky E, Hed J, Skogh T. IgA anti‐endomysium antibodies have a high positive predictive value for for coeliac disease in asymptomatic patients. Allergy 1994; 49: 593–7
  • Lemer A, Kumar V, Iancu T C. Immunological diagnosis of childhood coeliac disease: comparison between antigliadin, antireticulin and antiendomysial antibodies. Clin Exp Immunol 1994; 95: 78–82
  • Diagnostic and statistical manual of mental disorders3rd ed. American Psychiatric Association, Washington, DC 1987
  • Eriksson S, Lindgren S. The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population. Scand J Gastroenterol 1984; 19: 971–6
  • Olsson R, Broomé U, Danielsson A, Hägerstrand I, Järnerot G, Lööf L, et al. Colchicine treatment of primary sclerosing cholangitis. Gastroenterology 1995; 108: 1199–203
  • Olsson R, Lindberg G, Weiland O, Nilsson L. Members of the Swedish Internal Medicine Liver Club and Clinics for Infectious Diseases. Chronic active hepatitis in Sweden. The etiologic spectrum, clinical presentation, and laboratory profile. Scand J Gastroenterol 1988; 23: 463–70
  • Verbaan H, Andersson K, Eriksson S. Intravenous drug abuse– the major route of hepatitis C virus transmission among alcohol‐dependent individuals?. Scand J Gastroenterol 1993; 28: 714–8
  • Beutner E H, Hale W L, Nisengard R J, Chorzelski T P, Holubar K. Defined immunofluorescence in clinical immunopathology. Immunopathology of the skin, E H Beutner, C TS. F Bean, R E Jordan. Dowden Hutchinson and Ross Inc, New York 1973; 225
  • Chorzelski T P, Sulej J, Tchorzewska H, Jablonska S, Beutner E H, Kumar V. IgA class endomysium antibodies (IgA EmA) in dermatitis herpetiformis and coeliac disease. Ann NY Acad Sci 1983; 420: 325
  • Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955; 19: 251–3
  • The genetics of human population, L L Cavalli‐Sforza, W F Bodmer. Freeman, San Francisco 1971; 827–8
  • Grodzinsky E, Franzen L, Hed J, Ström M. High prevalence of celiac disease in healthy adults revealed by antigliadin antibodies. Ann Allergy 1992; 69: 66–70
  • Grodzinsky E, Hed J, Liedén G, Sjögren F, Strom M. Presence of IgA and IgG antigliadin antibodies in healthy adults as measured by micro‐E. L. I. S. A. Int Arch Allergy Appl Immunol 1990; 92: 119–23
  • Olerup O, Olsson R, Hultcrantz R, Broome U. HLA‐DR and HLA‐DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1995; 108: 870–8
  • Mackay I R, Tait B D. HLA association with autoimmune‐type chronic active hepatitis: identification oi'B8‐DRw3 haplotype by family studies. Gastroenterology 1980; 79: 95–8
  • Pawlotsky J ‐M, Roudot‐Thoraval F, Simmonds P, Mellor J, Ben Yahia M, André C, et al. Extrahepatic: immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122: 169–73
  • Czaja A J, Carpenter H A, Santrach P J, Moore S B. Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis. J Hepatol 1996; 24: 52–9
  • Pettersson A, Sjöberg K, Lernmark Å, Eriksson S. HLA genotypes in coeliac disease and healthy individuals carrying gliadin antibodies. Eur J Gastroenterol Hepatol 1993; 5: 445–50
  • Laskin C A, Vidins E, Blendis L M, Soloninka C A. Autoantibodies in alcoholic liver disease. Am J Med 1990; 89: 129–33
  • Hallert C, Gotthard R, Jansson G, Norrby K, Walan A. Similar prevalence of coeliac disease in children and middle‐aged adults in a district of Sweden. Gut 1983; 24: 389–91

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.